Dean Gray, PhD, MBA
Vice President of Defense and Health
Dr. Dean Gray is responsible for MRIGlobal’s business operations across national security and defense and global health profit and loss units. These program portfolios include biosurveillance, chemical threat detection, disease diagnostics, emerging technologies, pharmaceutical sciences, engineering systems integration, and medical research.
Dean started his career in life sciences at MRIGlobal in 2002, following the events of 9/11, serving in numerous positions as a scientist, principal investigator, program manager, resource manager and director working with customers across broad areas of the Department of Defense, Homeland Security, U.S. military branches, and the National Institutes of Health.
He previously directed MRIGlobal’s programs for the Department of Defense Ebola Virus eradication efforts in West Africa, and developed related programs with the Department of State to design and build the first-of-its-kind biocontainment human transport unit, which won an R&D100 Award. He was the founding director of MRIGlobal’s Office of Strategy Management, and helped the institute design and manage the change into a new operating model in 2020.
The ISR Division specializes in the test, evaluation, and development of early-stage chemical and biological sensor technologies, training, and modification of off-the-shelf wearable products to better support special mission requirements. Dean and his team work with global commercial companies and governments to apply advanced technologies to new applications and customers in support of warfighter protection, disaster response, and countering weapons of mass destruction.
Dean was the capture manager and technical director for the Department of Defense Ebola Virus eradication efforts in West Africa, where his team deployed mobile laboratories to multiple locations in Sierra Leone and Guinea to provide near-real-time diagnostic disease analyses. These self-sufficient mobile laboratories were the first to deploy advanced robotic sample handling equipment outside of controlled laboratory conditions to reduce the time from sample to answer from days to hours. These efforts helped West Africa become “Ebola free” in January 2016.
In a parallel effort, Dean directed a program through the Department of State and the Paul Allen Foundation to develop a first-of-its-kind commercial aircraft-compatible human transport unit, which allows medical staff to care for up to eight highly contagious patients in transit around the globe. This unique combination of high pathogen containment, real-time physiological monitoring, and rugged air transport – the Containerized Bio-containment System – was the winner of an R&D100 award.
Dean serves on the Board of Directors of the Alliance for Sustainable Energy, which manages and operates the National Renewable Energy Laboratory (NREL) for the Department of Energy. In this role, he serves as chair of the Commercialization and Deployment committee and previously served on the Science and Technology Committee.
PhD, Forestry, University of Missouri
MS, Forestry, University of Missouri
MBA, University of Missouri at Kansas City
BA, Anthropology, Ohio University
Current Professional Organizations
National Defense Industrial Association
Program Management Institute
Gray, D. E., G. E. Rottinghaus, H. E, Garrett, and S. G. Pallardy, “Simultaneous Determination of the Predominant Hyperforins and Hypericins in St. John’s Wort (Hypericum perforatum L.) by Liquid Chromatography,” J AOAC Int. 83:944–949 (2000).
Gray, D. E., G. E. Rottinghaus, C. Roberts, H. E. Garrett, and S. G. Pallardy, “Quantification of Root Chicoric Acid in Purple Coneflower by Near Infrared Reflectance Spectroscopy,” Crop Science 41:1159–1161 (2001).
Gray, D. E., S. G. Pallardy, H. E. Garrett, and G. E. Rottinghaus, “Acute Drought Stress and Time of Harvest on Phytochemistry and Dry Weight of St. John’s Wort Leaves and Flowers,” Planta Med 69:1024–1030 (2003).
Gray, D. E., S. G. Pallardy, H. E. Garrett, and G. E. Rottinghaus, “Acute Drought Stress and Plant Age Effects on Alkamide and Phenolic Acid Content in Purple Coneflower Roots,” Planta Med 69:50–59 (2003).
Gray, D. E., A. Porter, T. O’Neill, R. K. Harris, and G. E. Rottinghaus, “A Rapid Cleanup Method for the Isolation and Concentration of Pyrrolizidine Alkaloids in Comfrey Root,” J AOAC Int 87:1049–1057 (2004).
Gray, D. E., K. LeVanseler, and M. Pan, “Single Laboratory Validation for the Determination of Flavonol Aglycones in Ginkgo biloba Dietary Supplement Crude Materials and Finished Products by High Performance Liquid Chromatography,” J AOAC Int 88:692–702 (2005).
Gray, D. E., D. Messer, A. Porter, S. Ferguson, R. K. Harris, A. P. Clark, D. Overstreet, and C. Smith, “Simultaneous Quantification of Flavonol Aglycones and Terpenelactones in Hydrolyzed Ginkgo biloba Extract Using High Performance Liquid Chromatography and Ultraviolet/Evaporative Light Scattering Detection,” J AOAC Int 88:1613–1620 (2005).
Gray, D. E., R. Upton, A. Chandra, A. Porter, and R. K. Harris, “Quantitative Analysis of Flavonol Glycosides in Ginkgo biloba: A Comparative Review of Analytical Methods,” Phytochem Anal 17:56–62 (2006).
Sasagawa, M., N. B. Cech, D. E. Gray, G. W. Elmer, and C. A. Wenner, “Echinacea alkylamides inhibit interleukin-2 production by Jurkat human, leukemic T cells,” International Immunopharmacology 6:1214–1221 (2006).
Gray, D. E., K. LeVanseler, M. Pan, and E. Waysek, “Evaluation of a Method for the Determination of Flavonol Aglycones in Ginkgo biloba Dietary Supplement Crude Materials and Finished Products by High Performance Liquid Chromatography: Collaborative Study,” J AOAC Int 90:43–53 (2007).
Croom, E., R. Pace, A. Paletti, N. Sardone, and D. E. Gray, “Single Laboratory Validation for the Determination of Terpene Lactones in Ginkgo biloba Dietary Supplement Crude Materials and Finished Products by High Performance Liquid Chromatography with Evaporative Light Scattering Detection,” J AOAC Int 90:647–658 (2007).
Greene, L. A., I. Isaac, D. E. Gray, and S. A. Schwartz, “Streamlining Plant Sample Preparation: The Use of High-Throughput Robotics to Process Echinacea Samples for Biomarker Profiling by MALDI-TOF Mass Spectrometry,” J Bio Tech 18:238–244 (2007).
Gray, D. E., D. Messer, A. Porter, B. Hefner, D. Logan, R. K. Harris, A. P. Clark, J. A. Algaier, J. D. Overstreet, and C. S. Smith, “Analysis of Flavonol Aglycones and Terpenelactones in Ginkgo biloba Extract: A Comparison of HPTLC and HPLC,” J AOAC Int 90:1203–1209 (2007).
Thomas, A. L., R. J. Crawford, G. E. Rottinghaus, J. K. Tracy, W. L. Applequist, B. E. Schweitzer, L. J. Havermann, S. F. Woodbury, J. S. Miller, M. R. Ellersieck, and D. E. Gray, “Occurrence of 23-epi-26-Deoxyactein and Cimiracemoside A in various Black Cohosh Tissues throughout the Growing Season,” HortScience 42:535–539 (2007).
Roman, M. C., D. E. Gray, J. Laurensen, G. Luo, R. McClanahan, R. Perez, C. Roper, V. Roscoe, C. Shevchuk, E. Suen, and D. Sullivan, “Determination of Ephedra Alkaloids in Urine and Plasma by HPLC-UV: Collaborative Study,” J AOAC Int. 87(1): 15–24 (2008).